Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

Patients are asked to obtain Ozempic with a valid prescription ... drugmaker announced Thursday. New study reaffirms strong link between hearing loss, dementia in seniors ST. PAUL, Minn., ...

I am concerned the mad scramble to get hold of weight-loss jabs has led to a Wild West market, where it's easy to buy these ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

Semaglutide (Ozempic ... a blood biomarker of Alzheimer’s improved in people who changed their lifestyle, but worsened in those who did not. The study involved only around 50 people, and ...